Published in:
01-09-2009 | Article
A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis
Authors:
S. M. Blackman, S. Hsu, S. E. Ritter, K. M. Naughton, F. A. Wright, M. L. Drumm, M. R. Knowles, G. R. Cutting
Published in:
Diabetologia
|
Issue 9/2009
Login to get access
Abstract
Aims/hypothesis
Insulin-requiring diabetes affects 25–50% of young adults with cystic fibrosis (CF). Although the cause of diabetes in CF is unknown, recent heritability studies in CF twins and siblings indicate that genetic modifiers play a substantial role. We sought to assess whether genes conferring risk for diabetes in the general population may play a risk modifying role in CF.
Methods
We tested whether a family history of type 2 diabetes affected diabetes risk in CF patients in 539 families in the CF Twin and Sibling family-based study. A type 2 diabetes susceptibility gene (transcription factor 7-like 2, or TCF7L2) was evaluated for association with diabetes in CF using 998 patients from the family-based study and 802 unrelated CF patients in an independent case–control study.
Results
Family history of type 2 diabetes increased the risk of diabetes in CF (OR 3.1; p = 0.0009). A variant in TCF7L2 associated with type 2 diabetes (the T allele at rs7903146) was associated with diabetes in CF in the family study (p = 0.004) and in the case–control study (p = 0.02; combined p = 0.0002). In the family-based study, variation in TCF7L2 increased the risk of diabetes about three-fold (HR 1.75 per allele, 95% CI 1.3–2.4; p = 0.0006), and decreased the mean age at diabetes diagnosis by 7 years. In CF patients not treated with systemic glucocorticoids, the effect of TCF7L2 was even greater (HR 2.9 per allele, 95% CI 1.7–4.9, p = 0.00011).
Conclusions/interpretation
A genetic variant conferring risk for type 2 diabetes in the general population is a modifier of risk for diabetes in CF.